OCV Partners is a Los Angeles-based venture capital firm that invests in companies with differentiated technologies in compelling target markets. It focuses on technology (SaaS, FinTech, PropTech) and healthcare (Healthcare SaaS, Digital Health, MedTech, Biotech) sectors across seed to growth stages.
Average disclosed round size is $43.8M (across 22 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
24 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Rad AI | Series C | $8M | May 2025 |
| Rad AI | Series C | $60M | Jan 2025 |
 Orca AI | Series B | $23M | May 2024 |
 ByHeart | Growth | $95M | May 2024 |
| Rad AI | Series B | $50M | Apr 2024 |
 Mermaid | Seed | $7.5M | Jan 2024 |
| Rad AI | Series B | $50M | Jan 2024 |
 Ozette | Series A | $26M | Jul 2022 |
 Ozette | Series A | $26M | Jul 2022 |
| Rad AI | Series A | $25M | Nov 2021 |
| ByHeart | Series B | — | Jul 2021 |
| Orca AI | Series A | $13M | Apr 2021 |
 Praxis Precision Medicines | Series C | $110M | Jul 2020 |
| ByHeart | Series A | $70M | Apr 2020 |
| FFigure8 | Series A | $40M | Aug 2019 |
 Museum of Ice Cream | Unknown | $40M | Aug 2019 |
 Ossio | Series C | $35M | Jan 2019 |
| FFigure8 | Series A | $40M | Jan 2019 |
 Invoice2go | Series A | $10M | Sep 2018 |
 Precision BioSciences | Series B | $110M | — |
 SafeBreach | Series D | $53.5M | — |
| SafeBreach | Series C | $19M | — |
| FFinch Therapeutics Group | Growth | — | — |
| FFinch Therapeutics Group | Series C | $53M | — |
Top Co-Investors
World Innovation Lab4 shared
Khosla Ventures4 shared
Gaingels4 shared
UP23983 shared
Cone Health3 shared
Alphabet Inc.3 shared
Gradient Ventures3 shared
Kickstart Ventures3 shared
Elizabeth Street Ventures3 shared
Maywic Select Investments3 shared
D1 Capital Partners3 shared
Two River3 shared
Polaris Partners3 shared
Cormorant Asset Management3 shared
Alexandria Venture Investments3 shared
Sequoia Capital3 shared
Martin Ventures2 shared
Mirana Ventures2 shared
Transformation Capital2 shared
BECO Capital2 shared
Last updated: 20 October 2026